Welcome to our dedicated page for Churchill Capital XIII SEC filings (Ticker: XIIIU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Churchill Capital XIII's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Churchill Capital XIII's regulatory disclosures and financial reporting.
Churchill Capital Corp XIII (XIIIU) reports that holders of its units from the initial public offering, each unit consisting of one Class A ordinary share with par value $0.0001 and one-tenth of one redeemable warrant, may begin separately trading the shares and warrants commencing September 18, 2026.
Each whole warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share. Units will continue to trade on the Nasdaq Global Market under the symbol “XIIIU”, while separated Class A ordinary shares and warrants are expected to trade under “XIII” and “XIIIW”, respectively. No fractional warrants will be issued and only whole warrants will trade.
Churchill Capital Corp XIII received a Schedule 13G from several Millennium-affiliated entities reporting significant holdings of its Class A ordinary shares. Integrated Core Strategies (US) LLC reported beneficial ownership of 2,258,778 shares, representing 5.4% of the class, all with shared voting and dispositive power.
Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each reported beneficial ownership of 3,368,778 shares, or 8.1% of the class, all with shared voting and dispositive power and no sole power. The filing explains that these securities are held by entities subject to voting control and investment discretion of Millennium Management and related managers, and expressly states that this should not, by itself, be construed as an admission of beneficial ownership. The reporting persons also entered into a joint filing agreement dated August 6, 2026.
Churchill Sponsor XIII LLC, together with Michael Klein and M. Klein Associates, Inc., reports beneficial ownership of 14,150,000 Ordinary Shares of Churchill Capital Corp XIII, representing 25.47% of the 55,550,000 Ordinary Shares outstanding as of August 3, 2026. This stake comprises 350,000 Class A Ordinary Shares acquired as Placement Units and 13,800,000 Class B Founder Shares that are automatically convertible into Class A shares on a one-for-one basis in connection with the initial business combination.
The Sponsor originally purchased 14,375,000 Founder Shares for $25,000, and later acquired 350,000 Placement Units at $10.00 per unit in the IPO; the aggregate purchase price for the reported holdings is $3,525,000, funded from the Sponsor’s working capital. Churchill Capital Corp XIII is a blank check company formed to pursue a business combination, and under an Insider Letter the Sponsor and Klein have agreed to vote their Founder and placement shares in favor of any proposed business combination and not to redeem these shares.
The Placement Units and underlying securities are subject to lock-up restrictions until 30 days after the initial business combination. The Sponsor has also agreed to indemnify the company to help maintain at least $10.00 per public share in the Trust Account in a liquidation scenario, subject to specified conditions and limits.
Churchill Capital Corp XIII, a Cayman Islands SPAC, completed its IPO on August 3, 2026, issuing 41,400,000 units at $10.00 each, including full exercise of the over-allotment, for $414,000,000 in gross proceeds. Each unit includes one Class A ordinary share and one-tenth of a redeemable warrant, with each whole warrant exercisable at $11.50 per share. Simultaneously, the sponsor bought 350,000 Private Placement Units for $3,500,000.
A total of $414,000,000 was placed in a U.S. trust account, while the August 3, 2026 balance sheet shows total assets of $415,465,502, including $767,080 in cash outside the trust. Transaction costs were $19,058,909, and liabilities include a $16,990,000 deferred underwriting fee. There are 41,400,000 Class A shares classified as redeemable at $10.00 per share and 13,800,000 Class B Founder Shares outstanding. The company has 4,140,000 Public Warrants and 35,000 Private Warrants, and an auditor issued an unqualified opinion. Management states current liquidity and the Combination Period provide sufficient funds for at least one year while it seeks an Initial Business Combination requiring at least 80% of trust assets in fair market value.
Churchill Sponsor XIII LLC, associated with Michael Stuart Klein of Churchill Capital Corp XIII, purchased 350,000 Class A ordinary shares on 2026-08-03 at $10.00 per share through private placement units. These shares are held indirectly, with Klein potentially deemed a beneficial owner through M. Klein Associates, Inc., while he disclaims beneficial ownership beyond any pecuniary interest. Following the transaction, the reporting group’s indirect holdings in these shares total 350,000.
Churchill Capital Corp XIII, a Cayman Islands SPAC, completed its upsized initial public offering of 41,400,000 units at $10.00 per unit, including the full exercise of the underwriter’s over-allotment option, generating $414,000,000 in gross proceeds. Each unit includes one Class A ordinary share and one-tenth of one redeemable warrant, with each whole warrant exercisable at $11.50 per share.
The company also sold 350,000 Private Placement Units to its sponsor for $3,500,000. A total of $414,000,000, consisting of $411,000,000 of IPO net proceeds (including up to $15,490,000 of deferred underwriting discount) and $1,500,000 of private placement proceeds, was deposited into a U.S.-based trust account. These funds remain in trust until a business combination or required redemptions, generally within 24 months of the IPO closing (extendable to 27 months under specified conditions). The company adopted amended and restated charter documents and appointed William Sherman to its board and key committees, while entering into indemnification agreements with directors and officers.